Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-14

Clinical Trial Update: Topical 2% Lidocaine for the Treatment of Symptomatic Hemorrhoids [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating topical 2% lidocaine for symptomatic hemorrhoids is ongoing in Phase 2 and Phase 3, with current status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (2% topical) (lidocaine)

Snippet

Sponsor: University Hospital Dubrava | Conditions: Hemorrhoids | Phase 2, Phase 3 | Status: UNKNOWN